Artificial Blood Market Size, Share and Forecast 2026
The Artificial Blood Market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 12, 2019 ) Market Overview:
Artificial blood to made act as a substitute for red blood cells. While true blood perform different functions but artificial blood is designed for the purpose of transporting oxygen and carbon dioxide through the body.
Based on the type of artificial blood it can be produced in different ways it includes synthetic production, chemical isolation or recombinant biochemical technology. For decades scientists have been trying to develop artificial blood through various sources to address the shortage of blood transfusions.
Market Dynamics:
Increase in shortage of transfusable blood stocks, trauma death due to lack of availability of blood during operations and increase in number of deaths by hemorrhagic shock ( it is a form of hypovolemic shock in which severe blood loss leads to inadequate oxygen delivery at the cellular level) globally are driving the Artificial Blood Market during the forecast period.
Major factors hindering the Artificial Blood Market during the forecast period are expansive, lack of awareness and adverse side effects associated with the usage of the artificial blood.
Market Segmentation:
By Product Type
• Hemoglobin-based Oxygen carriers
• Perfluorocarbon emulsion
By Source
• Human Hemoglobin
• Animal Hemoglobin
• Stem Cells
• Synthetic Polymers
• Microorganisms
• Others
By Application
• Anemia
• Organ Transplant
• Injuries & Trauma
• Cardiovascular diseases
• Maternal conditions
• Others
By Distribution Channel
• Hospitals
• Clinics
• Blood banks
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• FLUORO2 Therapeutics
• Kalocyte
• Hemarina
• North Field Laboratories
• Biopure Corporation
• Sangart Corporation
• Others
View full report: https://www.datamintelligence.com/research-report/artificial-blood-market
Download free sample: https://www.datamintelligence.com/download-sample/artificial-blood-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Artificial blood to made act as a substitute for red blood cells. While true blood perform different functions but artificial blood is designed for the purpose of transporting oxygen and carbon dioxide through the body.
Based on the type of artificial blood it can be produced in different ways it includes synthetic production, chemical isolation or recombinant biochemical technology. For decades scientists have been trying to develop artificial blood through various sources to address the shortage of blood transfusions.
Market Dynamics:
Increase in shortage of transfusable blood stocks, trauma death due to lack of availability of blood during operations and increase in number of deaths by hemorrhagic shock ( it is a form of hypovolemic shock in which severe blood loss leads to inadequate oxygen delivery at the cellular level) globally are driving the Artificial Blood Market during the forecast period.
Major factors hindering the Artificial Blood Market during the forecast period are expansive, lack of awareness and adverse side effects associated with the usage of the artificial blood.
Market Segmentation:
By Product Type
• Hemoglobin-based Oxygen carriers
• Perfluorocarbon emulsion
By Source
• Human Hemoglobin
• Animal Hemoglobin
• Stem Cells
• Synthetic Polymers
• Microorganisms
• Others
By Application
• Anemia
• Organ Transplant
• Injuries & Trauma
• Cardiovascular diseases
• Maternal conditions
• Others
By Distribution Channel
• Hospitals
• Clinics
• Blood banks
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• FLUORO2 Therapeutics
• Kalocyte
• Hemarina
• North Field Laboratories
• Biopure Corporation
• Sangart Corporation
• Others
View full report: https://www.datamintelligence.com/research-report/artificial-blood-market
Download free sample: https://www.datamintelligence.com/download-sample/artificial-blood-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.